Olga Yu. Tkachenko

Olga Yu. Tkachenko

Auto-generated profile, based on publicly available information

Olga Yu. Tkachenko

First Pavlov State Medical University

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2019 in Clinical Immunology
Verified
Journal Article
Closed access
OTOlga Tkachenko
Olga Tkachenko
SLSergey Lapin
Sergey Lapin
AMAlexey Maslyansky
Alexey Maslyansky
VMValentina Myachikova
Valentina Myachikova
LMLiya Mikhailova
Liya Mikhailova
BGBoris Gilburd
Boris Gilburd

4 March 2019 in Autoimmunity Reviews
Verified
Journal Article
Closed access
OTOlga Tkachenko
Olga Tkachenko
SLSergey Lapin
Sergey Lapin
AMAlexey Maslyansky
Alexey Maslyansky
VMValentina Myachikova
Valentina Myachikova
VGVeronika Guseva
Veronika Guseva
BGBoris Gilburd
Boris Gilburd

30 January 2020 in Pulmonary Medicine
Verified
Journal Article
Open access
PDF file
MPMargarita Y. Pervakova
Margarita Y. Pervakova
Alexandra MazingAlexandra Mazing
Alexandra Mazing
SLSergey V. Lapin
Sergey V. Lapin
OTOlga Y. Tkachenko
Olga Y. Tkachenko
ABAnna I. Budkova
Anna I. Budkova
OTOlga N. Titova
Olga N. Titova
Chronic obstructive pulmonary disease (COPD) is multifactorial disease, which is characterized by airflow limitation and can be provoked by genetic factors, including carriage of the PiZ allele of the protease inhibitor (Pi) gene, encoding alpha-1 antitrypsin (A1AT). Both homozygous and heterozygous PiZ allele carriers can develop COPD. It was found recently that normal A1AT regulates cytokine levels, including IL-17, which is involved in COPD progression. The aim of this study was to determine whether homozygous or heterozygous PiZ allele carriage leads to elevated level of IL-17 and other proinflammatory cytokines in COPD patients. Materials and Methods. Serum samples and clinical data were obtained from 44 COPD patients, who included 6 PiZZ, 8 PiMZ, and 30 PiMM A1AT phenotype carriers. Serum concentrations of IL-17, IL-6, IL-8, IFN-γ, and TNF-α were measured by the enzyme-linked immunosorbent assay (ELISA). All A1AT phenotypes were verified by narrow pH range isoelectrofocusing with selective A1AT staining. A turbidimetric method was used for quantitative A1AT measurements. Results. COPD patients with both PiZZ and PiMZ phenotypes demonstrated elevated IL-17 and decreased IFN-γ levels in comparison to patients with the PiMM phenotype of A1AT. Thereafter, the ratio IL-17/IFN-γ in PiZZ and PiMZ groups greatly exceeded the values of the PiMM group. Homozygous PiZ allele carriers also had significantly higher levels of IL-6 and lower levels of IL-8, and IL-6 values correlated negatively with A1AT concentrations. Conclusions. The presence of the PiZ allele in both homozygous and heterozygous states is associated with altered serum cytokine levels, including elevated IL-17, IL-17/IFN-γ ratio, and IL-6 (only PiZZ), but lower IFN-γ and IL-8.

10 January 2021 in Medical Immunology (Russia)
Verified
Journal Article
Open access
PDF file
OTO. Yu. Tkachenko
O. Yu. Tkachenko
SLSergey V. Lapin
Sergey V. Lapin
Alexandra MazingAlexandra Mazing
Alexandra Mazing
ATAreg Artemovich Totolian
Areg Artemovich Totolian
Antinuclear antibodies (ANAs) represent a spectrum of autoantibodies targeted for various nuclear and cytoplasmic components of the cells. Indirect immunofluorescence assay (IIF) is the main detection method for “antinuclear factor”. A positive ANA test is usually reported as a titer and a pattern of fluorescence. The ANA patterns refers to the distribution of staining produced by antibodies that react with antigens located in nucleus and cytoplasm of HEp-2 cells. To standardize nomenclature and descriptions of the various fluorescence patterns of antinuclear factor (ANF), the Initiative of the International Consensus on ANA Patterns (ICAP) group was developed in 2014. The aim of ICAP is to promote consensus regarding nomenclature of ANA patterns, a microphotograph database, as well as classification depending on the employee skills. Information on the main characteristics, as well as specific clinical associations of the patterns is available at www.ANApatterns.org. In ANA classification trees, the patterns are indicated by the #AC (anticell pattern) alphanumeric code, being divided into nuclear, cytoplasmic and mitotic groups. Depending on the clinical significance and/or ease of recognition, this nomenclature focuses on the differences between the patterns described by specialists at competent and expert levels. Of the nuclear types, the most significant are homogeneous, speckled, dense fine-speckled, centromere, nucleolar, nuclear dots. The cytoplasmic types may be discerned into fibrillar, speckled, mitochondrial, Golgi, rods and rings. On leaders, behalf of the ICAP translation team is headed by the Full Member of Russian Academy of Sciences, Professor A.A. Totolian, under the auspices of the Russian Research Society of Immunologists. In this article, we present the Russianlanguage adaptation of the ICAP nomenclature, in order to ensure unification and standardization of ANA detection results in the patients with autoimmune diseases.

1 January 2022 in Immunologiya
Verified
Journal Article
Closed access
PFPavlov First Saint Petersburg State Medical University of the Ministry of Healthcare of the Russian Federation
Pavlov First Saint Petersburg State Medical University of the Ministry of Healthcare of the Russian Federation
MPM.YU. Pervakova
M.YU. Pervakova
VPV.G. Potapenko
V.G. Potapenko
SPSaint-Petersburg State Budgetary Healthcare Institution «Municipal Clinical Hospital No. 31» of the Health Committee of Saint Petersburg
Saint-Petersburg State Budgetary Healthcare Institution «Municipal Clinical Hospital No. 31» of the Health Committee of Saint Petersburg
OTO.YU. Tkachenko
O.YU. Tkachenko
VEV.L. Emanuel
V.L. Emanuel
Цитокиновые паттерны летальных гипервоспалительных состояний, индуцированных вторичным гемофагоцитарным синдромом, бактериальным сепсисом и COVID-19

6 November 2018 in Medical Immunology (Russia)
Verified
Journal Article
Open access
PDF file
OTO. Yu. Tkachenko
O. Yu. Tkachenko
СЛС. В. Лапин
С. В. Лапин
ASA. A. Shmonin
A. A. Shmonin
LSL. N. Solovyova
L. N. Solovyova
EBE. A. Bondareva
E. A. Bondareva
DRDirk Roggenbuck
Dirk Roggenbuck
Лабораторная диагностика антифосфолипидного синдрома (АФС) состоит в выявлении антифосфолипидных антител (АФА) методом иммуноферментного анализа (ИФА), а именно в детекции антикардиолипиновых (аКл) антител и антител к бета-2-гликопротеину (aβ2GP1). Использование классических ИФА тест-систем затруднено их недостаточной стандартизацией. Новым подходом к детекции антифосфолипидных антител является использование мультиплексного лайн-блоттинга (ЛБ), преимуществом которого является сорбция антигенов на гидрофобной PVDF-мембране и детекция спектра АФА. Целью данного исследования является анализ диагностической ценности нового ЛБ в постановке серологического диагноза АФС. Нами была собрана коллекция образцов сывороток 45 пациентов с некардиоэмболическими ишемическими инсультами, 19 пациентов с рецидивирующими тромбозами глубоких вен нижних конечностей и 44 пациента с привычным невынашиванием беременности, а также 50 клинически здоровых доноров. В данных сыворотках были измерены аКл IgG, аКл IgM, aβ2GP1 методом ИФА с помощью тест-систем фирм Euroimmun (ПР1) и Orgentec Diagnostica (ПР2) и аКл IgG, аКл IgM, aβ2GP1, а также некритериальные АФА – методом иммуноблоттинга на тест-системе фирмы Medipan (ПР3). При использовании ИФА тест-систем ПР1 аКл и aβ2GP1 детектировались у 30,5 % пациентов. ИФА методом на тест-системах ПР2 АФА были обнаружены у 38% пациентов. Методом ЛБ аКл и aβ2GP1 были выявлены у 30% пациентов. Встречаемость средних и высоких титров АФА, измеренных методом ИФА на тест-системах ПР1 и ПР2, составила 12 и 11% соответственно, а методом ЛБ – 16,6%. При анализе спектра АФА методом ЛБ чаще всего обнаруживались aβ2GP1, аФс, аКл, аАн V, аФк. Метод мультиплексного лайн-блоттинга ЛБ показывает более высокую чувствительность при детекции средних и высоких титров АФА, а также позволяет выявить пациентов с множественной АФА позитивностью.